Last reviewed · How we verify
NCT04045236: FUCORE
AIMS Academy Clinical Research Network - Non Metastatic Rectal Cancer Operated on With Curative Intent
trial testing Registry in Non Metastatic Rectal Cancer. Withdrawn.
1 December 2021
Quick facts
| Lead sponsor | Niguarda Hospital |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 October 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Registry — full drug profile →
Conditions studied
- Non Metastatic Rectal Cancer — all drugs for Non Metastatic Rectal Cancer →
Sponsor
Niguarda Hospital
Who can join
18 and older, any sex, with Non Metastatic Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary purpose of this registry is to prospectively collect data from different Mini-invasive Colo-rectal Units in Northern Italy with a standardization of the pre-operative, intra-operative and post operative setting for patients operated on for non metastatic rectal cancer with curative intent. The secondary aim is to collect in a registry the compliance to oncological treatments and the oncological outcomes for the same patients
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Creation of a rectal cancer registry in Italy by the Advanced International Mini-Invasive Surgery (AIMS) academy clinical research network.
Mari GM, Achilli P, Maggioni D, Crippa J, et al · · 2019 · cited 1× · PMID 31723425 · DOI 10.12688/f1000research.20702.1
Verify or expand the search:
- PubMed search for NCT04045236
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Registry
Trials testing the same drug.
- NCT06998355 — BE.Amycon Registry UZ Leuven · suspended
- NCT06313944 — German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation · recruiting
- NCT06162546 — ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank · recruiting
- NCT05328050 — Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy) · recruiting
- NCT05438485 — Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia · terminated
Other Niguarda Hospital trials
Trials by the same sponsor.
- NCT05105399 — Evaluation of Serratus Plane Block on the Respiratory Pattern in Patients With Multiple Rib Fractures · NA · not yet recruiting
- NCT07153224 — The MICROSCOPE Project · not yet recruiting
- NCT04763993 — Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study · NA · not yet recruiting
- NCT07432347 — Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches · recruiting
- NCT07234409 — Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Mana · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04045236 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Niguarda Hospital
- Last refreshed: 23 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04045236.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing